📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CNS.
💹 Market Data
Market Cap$3.55B
Shares Outstanding51.41M
Float27.66M
Cash$252.95M
Debt$136.32M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 5.2% shares (2025Q4 vs prior)
1421 institutional holders · 716.18M shares
#1
VANGUARD GROUP INC
92.42M shares
#2
BlackRock, Inc.
72.78M shares
#3
Capital International Investors
47.43M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.16M
Days to Cover3.3
% of Float4.2%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CNS
📊 CNS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CNS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.